Michelle Faulk, Vice President and Controller at Atmos Energy Corp, has reported significant stock transactions in a recent SEC filing. The transactions, which took place on November 3, 2026, highlight the ongoing engagement of executives with the company’s equity. This activity is noteworthy as it reflects confidence in the company’s performance and future outlook.
Atmos Energy Corp, based in Dallas, Texas, operates within the natural gas distribution sector. The company is publicly traded under the ticker symbol ATO and is categorized under the SIC code for Natural Gas Distribution. As of the latest filings, Atmos Energy has been active in the market, with several recent disclosures regarding stock transactions by its executives.
According to the filing (accession number 0000731802-26-000133), Faulk acquired 520 shares of common stock at a price of $173.49 per share. Additionally, she disposed of 179 shares at the same price, indicating a strategic management decision regarding her equity stake in the company. Following these transactions, Faulk now holds a total of 1,729.388 shares directly, along with additional holdings through a retirement savings plan.
This activity may influence not only Atmos Energy’s internal dynamics but also the broader natural gas distribution industry. Executives' participation in stock ownership can signal confidence to investors and stakeholders, potentially impacting market perceptions. Other companies in the sector might take note of this trend as they assess their own executive engagement strategies.
Details regarding any upcoming filings or further actions by Faulk were not disclosed in the filing. The focus remains on the implications of these transactions for Atmos Energy and its standing within the natural gas distribution market.
Read Next
Holmes John McClain III reports stock transaction for GATX
Kodiak Gas Services CEO McKee Sells Shares Under Trading Plan
Finn Michael J acquires additional shares in Sanfilippo
Advisors Preferred Trust Files New Summary Prospectus
Lord Abbett Bond Debenture Fund updates portfolio management team
Recursion Pharmaceuticals reports change in ownership







